Interestingly, JNKs are well known to be activated in AD (Pei et al., 2001; Zhu et al., 2001; Yarza et al., 2015) and were previously implicated as a downstream effector of trafficking defects in tau knockout Drosophila (Voelzmann et al., 2016). This evidence concerns the gene MAPT and Alzheimer disease.